Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat, Youssef M.K. Farag et autres
98 citationsAnnals of Internal Medicine
Raymond Fink
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
15Publications signalées
2079Citations signalées
0Affiliations récentes
Domaines associés
Diabetes Treatment and ManagementDiabetes Management and ResearchPancreatic function and diabetesDiet and metabolism studiesMetabolism, Diabetes, and Cancer
Publications récentes
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888–897
Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et autres
0 citationsDiabetes Care
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt et autres
212 citationsDiabetes Care
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study
Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos et autres
37 citationsDiabetes Care
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen et autres
243 citationsDiabetes Care
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi, Darren K. McGuire et autres
95 citationsThe Lancet
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen et autres
295 citationsThe Lancet Diabetes & Endocrinology
Evidence that glucose transport is rate-limiting for in vivo glucose uptake
Raymond Fink, Penny Wallace, Ginger Brechtel, Jerrold M. Olefsky
81 citationsMetabolism
Effects of Aging on Insulin Secretion
Barry Gumbiner, Kenneth S. Polonsky, W F Beltz, Penny Wallace et autres
128 citationsDiabetes
Effects of aging on glucose-mediated glucose disposal and glucose transport.
Raymond Fink, Penny Wallace, Jerrold M. Olefsky
70 citationsJournal of Clinical Investigation
The Effects of Aging on Glucose Metabolism in Adipocytes from Fischer Rats*
Raymond Fink, T P Huecksteadt, Z. KARAOGHLANIAN
33 citationsEndocrinology
The Metabolic Clearance of Insulin and the Feedback Inhibition of Insulin Secretion Are Altered with Aging
Raymond Fink, R R Revers, Orville Kolterman, Jerrold M. Olefsky
76 citationsDiabetes
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.